WASHINGTON REPORT BY TAMIKA CARTER, DATIA
DOT Publishes Notice for Collectors, Laboratories, MROs, and Regulated Employers Regarding Expanded Opioid Testing Recently, the DOT published a notice for collectors, laboratories, medical review officers, and regulated employers regarding a final rule that amends its drug testing program regulation to add hydrocodone, hydromorphone, oxymorphone, and oxycodone to its drug-testing panel. Te rule also adds methylenedioxyamphetamine as an initial test analyte and removes methylenedioxyethylamphetamine as a confirmatory test analyte. Te final rule went into effect on January 1, 2018. To view the notice, visit the DOT’s website. htps://
www.transportation.gov/odapc/ DOT_5_Panel_Notice_2018
DEA Emergency Schedules All lIlicit Fentanyls Effective February 6, 2018, the U.S. Drug Enforcement Administration (DEA) placed all illicit fentanyl analogues not already regulated by the Controlled Substances Act into Schedule I—the category for substances with no currently accepted medical use. Illicit fentanyl analogues are substances intended for human consumption that are substantially similar in their chemical makeup and effects to fentanyls already listed in Schedule I. These substances will be listed in Schedule I for two years with the possibility of a one-year extension. The action is expected to reduce these substances’ flow into the country and slow the alarming increase in overdose deaths linked to synthetic opioids. For more information, view the Federal Register notice.
https://www.gpo.gov/fdsys/pkg/FR-2018- 02-06/pdf/2018-02319.pdf
26 datia focus DOT List Serve
Registration Required for Many As of January 1, 2018, all specimen collectors, breath alcohol technicians, screening test technicians, medical review officers, and substance abuse professionals are required to be subscribed to the U.S. Department of Transportation’s (DOT) List Serve. Each collector/BAT/STT must be individually subscribed. Just as collectors/BATs/STTs must maintain documentation of their qualification training and proficiency demonstration, so must verification of their list serve subscription. This subscription is a requirement to be qualified to perform DOT testing, so verification and documentation of the person’s subscription should be treated with as much importance as their qualification training and proficiency demonstration documentation. To subscribe, go to
https://www.transportation.gov/odapc/ get-odapc-email-updates, enter your email address, and follow the prompts.
DEA Adds 250 Officers to Fight Opioid Crisis On March 26, 2018, the U.S. Drug Enforcement Administration (DEA) announced that it would add 250 task force officers and dozens of additional analysts to areas across America where the opioid crisis is at its worst. DEA task forces act as a force multiplier in carrying out DEA’s mission through coordination and cooperation with federal, state, and local law enforcement agencies in the U.S. Historically, DEA task force officers have been some of the most essential and effective partners in building cases against drug trafficking organizations across the globe. For more information, visit the DEA website. htps://
www.dea.gov/ divisions/hq/2018/
hq032618.shtml ❚
spring 2018
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
